URGO Group
URGO Group is a privately-held French pharmaceutical and medical device company that manufactures wound care, consumer health, and complex pathology products under 20+ brands across more than 60 countries.
- Company typePrivate
- Founded1987
- HeadquartersParis, France
- Headcount1,001–5,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
URGO Group firmographics
Firmographics- Name
- URGO Group
- Legal name
- URGO SAS
- Website
- https://urgo-group.fr
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- URGO Group is a privately-held French pharmaceutical and medical device company that manufactures wound care, consumer health, and complex pathology products under 20+ brands across more than 60 countries.
- Ownership category
- akta.pro rank
Where URGO Group is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices5 records
Markets served
URGO Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical and Medical Products: URGO Group generates revenue through the sale of proprietary pharmaceutical products, medical devices, and health consumer products across wound care, consumer health, and complex pathology segments.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels2 records
URGO Group product offering
Product offeringCore offering
URGO Group is a French pharmaceutical and medical device company that manufactures and distributes healthcare products across three segments: wound care (advanced dressings and compression therapy), consumer health (OTC medicines, dietary supplements and personal hygiene products) and complex pathology (medical nutrition and treatments for specific pathological conditions). The company operates 12 industrial sites, manufactures approximately 80% of its products in France, and sells in more than 60 countries through 21 international subsidiaries and partnerships with pharmacy networks.
Product overview
URGO Group is a global pharmaceutical company organized around three core business segments: wound care (including advanced technologies like URGO K2), consumer health (spanning oral health, intimate care, and nutritional supplements), and complex pathology treatments. The company operates a multi-brand portfolio strategy, with the primary Urgo brand supported by acquired brands (Mercurochrome, Ricqlès) and specialized sub-brands. The portfolio emphasizes 'made in France' manufacturing, with approximately 80% of products produced domestically, and combines scientific expertise with cutting-edge medical technologies to serve healthcare professionals and patients across over 60 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Belloc: Marque de santé grand public
- Intimy Care
- Healico
- Urgo K2
- CicaManuka
- Comptoirs et Compagnies
- Herbesan
- OM3
- Intimy
- Marie Rose
- Eostra
- Mercurochrome
- Esprit Bio
- Juvamine
- Oligocéan
- Humer
- Alvityl
- Superdiet
- Urgo
- Ricqlès
- Juva Santé
- URGO Healthcare
- URGO Medical & Healthcare
Products and services
- URGO Wound Care Dressings Advanced wound dressings and wound care products using URGO's proprietary lipidocolloid matrix technology and Manuka honey-based formulations for the management of acute and chronic wounds. Sold to hospitals, pharmacies and healthcare professionals.
- URGO Compression Therapy (UrgoK2, UrgoK1) Multi-layer compression bandage systems for the treatment of venous leg ulcers, lymphedema and related vascular conditions. Targeted at healthcare professionals and institutions.
- Mercurochrome Recognized French antiseptic and minor wound care consumer brand sold in pharmacies and parapharmacies for everyday first-aid needs.
- Juvamine Range of dietary supplements (vitamins, minerals, beauty and slimming formulations) marketed to consumers through pharmacy and retail channels.
- Ricqlès Traditional Ricqlès mint concentrate and related herbal remedy products sold to consumers for digestive wellness.
- Humer Nasal hygiene and respiratory care products (saline sprays, decongestants) marketed to consumers for everyday respiratory wellness.
- Alvityl Range of vitamin, tonic and fortifying products for children and adults, sold through pharmacy channels.
- URGO Complex Pathology / Medical Nutrition Medical nutrition products and treatments targeting complex pathological conditions (such as rare dermatological conditions, scarring and post-surgical recovery), developed for healthcare professionals and patients.
Companies that use URGO Group
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
URGO Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
URGO Group partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- PitchercoreURGO Group partnered with Pitcher for commercial enablement across regulated industries. This partnership supports URGO's sales enablement initiatives, enhancing client engagement and data-driven content management. The partnership was announced alongside similar deals with Demant and Rabobank, representing continued adoption of Pitcher's sales enablement platform in healthcare and financial services.
Scale indicators12 records
Recent moves8 records
Expansion highlights6 records
URGO Group competitors and assessment
Company assessmentDirect peers
- Mölnlycke Health Care: Swedish global leader in wound care and surgical solutions, with Mölnlycke foam dressings and Avance negative pressure wound therapy as direct analogues to URGO's wound care portfolio. Highly comparable in product category, B2B healthcare professional GTM, and clinical focus.
- Coloplast: Danish medical device company specializing in wound care, ostomy, continence, and skin care. Operates a similar hospital-and-pharmacy distribution model with proprietary dressing technology, making it a strong peer for URGO's wound care and intimate care segments.
- ConvaTec: UK-listed medical products company focused on advanced wound care, ostomy care, continence care, and infusion sets. Highly comparable in product categories (advanced dressings, ostomy), hospital distribution model, and European manufacturing footprint.
- Paul Hartmann Group: German family-owned medical and hygiene products manufacturer with strong wound care and incontinence portfolios. Comparable business model as a privately-held, German-speaking European mid-cap focused on professional wound management and consumer hygiene.
- Smith & Nephew: UK-listed global medical technology company with an Advanced Wound Management division offering comparable products (Allevyn, PICO negative pressure wound therapy). Direct overlap in advanced wound dressings and hospital channel GTM.
Broad incumbents
- Beiersdorf: German consumer goods major owning Hansaplast/Elastoplast, the leading mass-market wound care brand in Europe. Overlaps with URGO's consumer wound care and OTC pharmacy channel strategy as a much larger incumbent with broader personal care portfolio.
- B. Braun: German medical and pharmaceutical device company with hospital-focused wound care, infusion therapy, and surgical products. Comparable in B2B hospital sales model and European manufacturing footprint, though much broader portfolio than URGO.
- 3M Health Care: US-listed conglomerate's Health Care division includes advanced wound care (Tegaderm) and surgical solutions. Comparable in advanced wound dressing technology and hospital GTM, though part of a much larger diversified industrial portfolio.
- Bayer Consumer Health: OTC and consumer health division of Bayer, with comparable pharmacy-distributed self-care brands (Bepanthen, Canesten) overlapping with URGO's consumer health portfolio. Much larger incumbent operating as a global pharma conglomerate.
- Perrigo: US-listed consumer self-care company focused on OTC pharmaceuticals, personal care, and nutritional products. Comparable in OTC consumer health distribution through pharmacy channels, particularly relevant to URGO's Juva Santé consumer health division.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
URGO Group social profiles
Digital presenceURGO Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
URGO Group leadership team
Management profileNumber of profiles
Profiles2 records
URGO Group subsidiaries and ownership
Company hierarchySubsidiaries2 records
URGO Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
URGO Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about URGO Group
What does URGO Group do?
URGO Group is a French pharmaceutical and medical device company that manufactures and distributes healthcare products across three segments: wound care (advanced dressings and compression therapy), consumer health (OTC medicines, dietary supplements and personal hygiene products) and complex pathology (medical nutrition and treatments for specific pathological conditions). The company operates 12 industrial sites, manufactures approximately 80% of its products in France, and sells in more than 60 countries through 21 international subsidiaries and partnerships with pharmacy networks.
Is URGO Group a public or private company?
URGO Group is a private company. It is classified as family owned and is currently operating.
When was URGO Group founded?
URGO Group was founded in 1987. It employs 1,001 to 5,000 people.
Where is URGO Group based?
URGO Group is headquartered in Paris, France, in the Europe region.
How does URGO Group make money?
One revenue line is on record: pharmaceutical and Medical Products.
Who are URGO Group's main competitors?
Direct peers on record are Mölnlycke Health Care, Coloplast, ConvaTec, Paul Hartmann Group and Smith & Nephew. Broad incumbents are Beiersdorf, B. Braun, 3M Health Care, Bayer Consumer Health and Perrigo.
Does URGO Group have an API?
No public API is recorded for URGO Group.